No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Devices
GN Store Nord A/S, a company founded in 1869 and based in Ballerup, Denmark, specializes in the development, production, and sale of audio and video communication solutions. Its offerings cater to medical, professional, and consumer technology sectors across Denmark, the rest of Europe, North America, and various international markets. The company operates through two distinct segments: GN Hearing and GN Audio. The GN Hearing division is responsible for manufacturing and distributing hearing instruments and related products. Meanwhile, the GN Audio segment supplies an array of devices such as headsets, video cameras, and speakerphones, designed for both professional applications and general consumer use. These products are available under well-known brands including ReSound, Beltone, Interton, Jabra, BlueParrott, FalCom, and Audigy.
www.gn.comNo one on the platform currently holds GN.CO.
No tracked institution reports a position in GN.CO as of their last filing.
No one on the platform has traded GN.CO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 6.7% | 7.3% | 10.9% | — | — | — |
| Rev. Growth % | -6.1% | 4.6% | ||||
| Profit Margin % | 3.9% | 4.9% | 8.1% | |||
| Free Cash Flow Margin % | 15.0% | 5.4% | 9.1% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $9.6B | -43.7% | $-0.47 | $-1.12–$-0.02 | — | 6 |
| 2027 | $10.0B | +4.2% | $3.53 | $2.09–$6.02 | — | 6 |
| 2028 | $10.4B | +4.3% | $5.56 | $3.66–$9.18 | — | 7 |
| 2029 | $10.8B | +3.5% | $5.07 | $4.77–$6.19 | — | 2 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-20 | $-0.59 | $-1.04 | -77.6% |
| 2026-05-06 | $0.96 | $-2.79 | -391.2% |
| 2026-02-05 | $2.87 | $2.35 | -18.1% |
| 2025-11-06 | $1.29 | $0.50 | -61.2% |
| 2025-08-21 | $1.22 | $1.13 | -7.4% |
| 2025-05-01 | $1.66 | $0.49 | -70.5% |
| 2025-02-06 | $2.42 | $2.84 | +17.4% |
| 2024-11-07 | $1.63 |
| $1.86 |
| +14.1% |
| $5M |
| — |
| CHEMM.COChemoMetec A/S | $501.50 | +1.85% | $8.7B | — |
| DEMANT.CODemant A/S | $299.00 | +1.08% | $63.1B | — |
Source: Financial Modeling Prep · peers by sector/industry